Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus vs NPH Insulin in Insulin-naive Type 2 Diabetes
NCT00941369Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2009
- Primary completion
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jun 2009; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00941369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941369.